期刊文献+

2型糖尿病合并非酒精性脂肪肝的血生化分析 被引量:1

下载PDF
导出
摘要 近年来,随着肥胖和2型糖尿病发病率的增加,糖尿病合并非酒精性脂肪肝(NAFLD)的发病率也明显增加,NAFLD成为危害人们健康的常见病。作者自2006年5月至2010年4月对本院诊断的2型糖尿病(T2DM)合并NAFLD患者的临床血生化指标进行了分析,探讨NAFLD的易患因素,以利于糖尿病及脂肪肝的预防和治疗。现报道如下。
作者 朱文娟
出处 《浙江临床医学》 2013年第5期673-674,共2页 Zhejiang Clinical Medical Journal
  • 相关文献

参考文献5

二级参考文献35

  • 1倪燕君,刘厚钰.脂肪肝的发病机理和诊断治疗[J].肝脏,1996,1(3):173-176. 被引量:10
  • 2胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 3范建高,魏国华.非酒精性脂肪性肝病的诊断[J].中华肝脏病杂志,2005,13(9):710-711. 被引量:13
  • 4Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 5Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.
  • 6Angulo P.Nonalcoholic fatty liver disease.N Engl J Med,2002,346:1221-1231.
  • 7Ghali P,Lindor KD.Hepatotoxicity of drugs used for treatment of obesity and its comorbidities.Semin Liver Dis,2004,24:389-397.
  • 8Harrison SA,Torgerson S,Hayashi P,et al.Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.Am J Gastroenterol,2003,98:2485-2490.
  • 9Angulo P.Use of ursodeoxycholic acid in patients with liver disease.Curr Gastroenterol Rep,2002,4:37-44.
  • 10Agrawal S,Bonkovsky HL.Management of nonalcoholic steatohepatitis:an analytic review.J Clin Gastroenterol,2002,35:253-261.

共引文献1667

同被引文献16

  • 1Giovanni Targher,Alessandro Mantovani, Isabella Pichiri. Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes[J]. Clinical Science ,2013, 125(6) :301-309.
  • 2Cone CJ, Bachyrycz AM, Murata GH. Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease [J]. The Annals of Pharmacotherapy, 2010,44 ( 10 ) : 1655- 1659.
  • 3Stefano Bonapace, Gianluea Perseghin, Giulio Molon. Non- alcoholic fatty liver disease is associated with left ventric- ular diastolic dysfunction in patients with type 2 diabetes[J]. Diabetes Care,2012,35 (2) :389-395.
  • 4Sunder Mudaliar,Robert RH,Arun JS,et al. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liv- er disease[J]. Gastroenterology, 2013,145 (3) : 574-582.
  • 5Nolan CJ. Failure of islet beta-cell compensation for in- sulin resistance causes type 2 diabetes: What causes non-alcoholic fatty liver disease and non-alcoholic steatohepatitis[J]. Journal of Gastroenterology and Hep- atology,2010,25 (10) : 1594-1597.
  • 6Konstantinos Tziomalos,Vassilios GA,Asterios Karagian- nis. Non-alcoholic fatty liver disease in type 2 diabetes : Pathogenesis and treatment options[J]. Current Vascu- lar Pharmacology,2012,10(2) : 162-172.
  • 7Marcin Kosmalski,Jacek Kasznicki ,Jozef Drzewoski. Re- lationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes[J]. Polskie Archiwum Medycyny Wewntrznej ,2013,123(9) :436--442.
  • 82007年版中国2型糖尿病防治指南[J].中华内分泌代谢杂志,2008,24(2). 被引量:269
  • 9非酒精性脂肪性肝病诊疗指南(2010年修订版)[J].中华肝脏病杂志,2010,18(3):163-166. 被引量:1158
  • 10闫焱,卞华,夏明锋,颜红梅,常薪霞,姚秀忠,饶胜祥,曾蒙苏,高鑫.住院2型糖尿病患者肝脏疾病谱调查及非酒精性脂肪性肝病相关危险因素分析[J].中华医学杂志,2013,93(4):270-274. 被引量:20

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部